Works matching IS 15233790 AND DT 2024 AND VI 26 AND IP 1
Results: 9
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 80, doi. 10.1007/s11912-023-01490-6
- By:
- Publication type:
- Article
Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 34, doi. 10.1007/s11912-023-01489-z
- By:
- Publication type:
- Article
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 21, doi. 10.1007/s11912-023-01487-1
- By:
- Publication type:
- Article
Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 65, doi. 10.1007/s11912-023-01486-2
- By:
- Publication type:
- Article
Assessing Frailty in Gastrointestinal Cancer: Two Diseases in One?
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 90, doi. 10.1007/s11912-023-01483-5
- By:
- Publication type:
- Article
Surgery for Recurrent Epithelial Ovarian Cancer.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 46, doi. 10.1007/s11912-023-01480-8
- By:
- Publication type:
- Article
Exploring DESTINY: the Past, Present, and Future of Trastuzumab Deruxtecan.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 1, doi. 10.1007/s11912-023-01478-2
- By:
- Publication type:
- Article
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 55, doi. 10.1007/s11912-023-01477-3
- By:
- Publication type:
- Article
Racial Disparities in Breast Cancer: from Detection to Treatment.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 1, p. 10, doi. 10.1007/s11912-023-01472-8
- By:
- Publication type:
- Article